Interventions to improve adverse drug reaction reporting: A scoping review.
adverse drug reaction
adverse drug reaction reporting systems
pharmacoepidemiology
pharmacovigilance
Journal
Pharmacoepidemiology and drug safety
ISSN: 1099-1557
Titre abrégé: Pharmacoepidemiol Drug Saf
Pays: England
ID NLM: 9208369
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
05
10
2019
revised:
19
12
2019
accepted:
03
01
2020
pubmed:
21
5
2020
medline:
3
7
2021
entrez:
21
5
2020
Statut:
ppublish
Résumé
Underreporting is the major limitation of a voluntary adverse drug reaction (ADR) reporting system. Many studies have assessed the effectiveness of different interventions designed to improve ADR reporting. The aim of this study was to systematically map interventions and strategies to improve ADR reporting among health care professionals. The six-stage methodological framework of Arksey and O'Malley was used to conduct this scoping review. Ovid MEDLINE, EMBASE, All EBM, and Web of Science were systematically searched from 1999 to February 2019, and the reference lists of the included papers were also searched for gray literature to identify any interventions and strategies that aimed to increase ADR reporting. Two reviewers screened the papers for eligibility based on the inclusion criteria and extracted their key data and analyzed them descriptively. Ninety out of 14 501 papers met the selection criteria. Using computerized registration and active surveillance can increase ADR reporting significantly. Educational interventions performed individually or combined with sending reminders and/or feedback, awards, and providing easier reporting channels can improve ADR reporting over a short to medium term. Multiple interventions may have more impact than single-component interventions. Multiple interventions could cause a greater increase in ADR reporting rates than single interventions. Although educational interventions appear to be effective, few studies have reviewed their long-term effects to ascertain whether the improvements are sustained over time. Studies with a better methodological quality are required on this subject.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
965-992Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Fang H, Lin X, Zhang J, et al. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacol Toxicol. 2017;18(1):49.
Ribeiro-Vaz I, Herdeiro MT, Polónia J, Figueiras A. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica. 2011;45(1):129-135.
Lapatto Reiniluoto O, Patinen L, Niemi M, Backman JT, Neuvonen PJ. Drug related inadvertent deaths in a university hospital-a declining trend. Basic Clin Pharmacol Toxicol. 2015;117(6):421-426.
Carrasco-Garrido P, de Andrés LA, Barrera VH, de Miguel GÁ, Jiménez-García R. Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006). BMC Health Serv Res. 2010;10(1):287.
Mouton JP, Njuguna C, Kramer N, et al. Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa. Medicine. 2016;95(19):e3437-e3437.
Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65(4):573-579.
Mouton JP, Mehta U, Parrish AG, et al. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. Br J Clin Pharmacol. 2015;80(4):818-826.
Patel TK, Patel PB. Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis. Eur J Clin Pharmacol. 2018;74(6):819-832.
Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf. 2017;26(6):635-641.
Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug, Healthcare and Patient Safety. 2012;4:75-80.
Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat M-C, Noize P, Haramburu F. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fund CLIN PHARMACOL. 2015;29(1):106-111.
Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437-453.
Stausberg J, Hasford J. Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data. BMC Health Serv Res. 2011;11:134.
Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847-857.
Edwards IR, Bencheikh RS. Pharmacovigilance is … vigilance. Drug Saf. 2016;39(4):281-285.
Fornasier G, Francescon S, Leone R, Baldo P. An historical overview over Pharmacovigilance. Int J Clin Pharmacol. 2018;40(4):744-747.
Haider N, Mazhar F. Factors associated with underreporting of adverse drug reactions by nurses: a narrative literature review. Saudi J Health Sci. 2017;6(2):71-76.
Anton C, Cox AR, Ferner RE. Improving follow-up rates in spontaneous adverse drug reaction reporting. Drug Saf. 2009;32(12):1135-1140.
Chang F, Xi Y, Zhao J, Zhang X, Lu Y. A time series analysis of the effects of financial incentives and mandatory clinical applications as interventions to improve spontaneous adverse drug reaction reporting by hospital medical staff in China. J Eval Clin Pract. 2017;23(6):1316-1321.
Hoffman KB, Dimbil M, Tatonetti NP, Kyle RF. A pharmacovigilance signaling system based on FDA regulatory action and post-marketing adverse event reports. Drug Saf. 2016;39(6):561-575.
Biagi C, Montanaro N, Buccellato E, Roberto G, Vaccheri A, Motola D. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). Eur J Clin Pharmacol. 2013;69(2):237-244.
Hazell L. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-396.
Lopez-Gonzalez E, Herdeiro MT, Piñeiro-Lamas M, Figueiras A. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Saf. 2015;38(2):189-196.
Varallo FR, Planeta CS, Mastroianni PC. Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics. 2017;72(1):51-57.
Tsuchiya M, Esashi A, Obara T, Inooka K, Mano N, Takamura C. Effect of educational interventions on adverse drug reaction reporting in a cancer Institute in Japan: a questionnaire study. Hosp Pharm. 2019;54(2):93-99.
Reumerman M, Tichelaar J, van Eekeren R, Richir M, Long Term v AM. Clinical effects of an Pharmacovigilance educational intervention in specialist oncology nurses. Drug Saf. 2018;41(11):1110-1110.
Pagotto C, Varallo F, Mastroianni P. Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care. 2013;29(4):410-417.
Ribeiro-Vaz I, Silva A-M, Santos CC, Cruz-Correia R. How to promote adverse drug reaction reports using information systems-a systematic review and meta-analysis. BMC Med Inform Decis Mak. 2016;16(1):27.
Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clin Epidemiol. 2009;1:75.
Ali S, Egunsola O, Al-Dossari DS, Al-Zaagi IA. Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy. Ther Adv Drug Saf. 2018;9(10):585-590.
Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317-328.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19-32.
Tricco AC, Lillie E, Zarin W, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016;16:15.
Agu KA, Oparah AC, Ochei UM. Improving monitoring and reporting of adverse drug reactions (ADRs) in HIV positive patients on antiretroviral therapy (ART) in Nigeria. Journal of Basic and Clinical Pharmacy. 2012;3(2):299-313.
Scott DR, Weimer M, English C, et al. A novel approach to increase residents' involvement in reporting adverse events. Acad Med. 2011;86(6):742-746.
Vázquez-Alvarez AO, Brennan-Bourdon LM, Rincón-Sánchez AR, Islas-Carbajal MC, Huerta-Olvera SG. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients. BMC Pharmacol Toxicol. 2017;18(1):79.
Macht R, Balen A, McAneny D, Hess D. A multifaceted intervention to increase surgery resident engagement in reporting adverse events. J Surg Educ. 2015;72(6):e117-e122.
Kheloufi F, Dupouey J, Belo S, et al. Using therapeutic drug monitoring to detect adverse drug reactions: a joint action of the clinical pharmacology laboratory and the regional Pharmacovigilance Center in Marseille. Fundamental and Clinical Pharmacology. 2016;30:67-68.
Goldman JL, Sullins A, Sandritter T, Leeder JS, Lowry J. Pediatric Pharmacovigilance: enhancing adverse drug reaction reporting in a tertiary care children's hospital. Ther Innov Regul Sci. 2013;47(5):566-571.
Schade CP, Hannah K, Ruddick P, Starling C, Brehm J. Improving self-reporting of adverse drug events in a West Virginia hospital. Am J Med Qual. 2006;21(5):335-341.
Patel S, Desai C, Dikshit R, Patel P. An impact of educational interventions on reporting of adverse drug reactions. Int J Pharm. 2015;5(2):485-492.
Darnis D, Mahé J, Vrignaud B, Guen CG-L, Veyrac G, Jolliet P. Adverse drug reactions in pediatric emergency medicine. Ann Pharmacother. 2015;49(12):1298-1304.
Anton C, Dussaye A, Badyal K, Ferner R. Influencing adverse drug reaction reporting in primary care. Drug Saf. 2017;40(10):997-998.
Khairnar A, Gade PR. Interventional improvement in hospital based intensive monitoring of adverse event. Int J Pharm Sci Drug Res. 2011;4(9):1443-1448.
Colodny L, Spillane J. Toward increased reporting of adverse drug reactions. Hosp Pharm. 1999;34(10):1179-1185.
Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child. 2001;84(4):337-339.
Lee SB, Schepers GP, Goldberg KL. Electronic adverse-drug-reaction-reporting program. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists. 2004;61(12):1230, 1232-1233-1232.
Bracchi RC, Houghton J, Woods FJ, Thomas S, Smail SA, Routledge PA. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. Br J Clin Pharmacol. 2005;60(2):221-223.
Mostella J, Throgmorton P, Cramer R. A systematic approach to improve reporting and analysis of adverse drug events. Pharmacotherapy. 2005;25(3):476-476.
Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother. 2005;39(7-8):1169-1174.
Ortega A, Aguinagalde A, Lacasa C, Aquerreta I, Fernández-Benítez M, Fernández LM. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother. 2008;42(10):1491-1496.
Park CS, Kim TB, Kim SL, et al. The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea. Pharmacoepidemiol Drug Saf. 2008;17(9):919-925.
Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008;102(4):408-411.
Sullivan KM, Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists. 2008;65(12):1177-1179.
Tabali M, Jeschke E, Bockelbrink A, et al. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009;9:274-274.
Gomez ES, Martinez MTG, Lenero VD, Ledesma MB, Saiz SG, Martin CB. Active pharmacovigilance in a hospital pharmacy department. Ejhp Practice. 2009;15(4):33-36.
Cereza G, Agusti A, Pedros C, et al. Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. Eur J Clin Pharmacol. 2010;66(9):937-945.
Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrenees region (PharmacoMIP) network 2-year pilot study. Drug Saf. 2010;33(5):409-416.
Shalviri G, Gholami K, Fazlollahi M. Drug safety officers and yellow boxes: new developments in reporting adverse drug reactions and medication errors in hospitals. Drug Saf. 2011;34(10):991.
Jacquot J, Gony M, Baudrin D, Chastel X, Montastruc JL, Bagheri H. Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP’s activities. Therapie. 2012;67(3):231-236.
Guédat M-G, Gouraud A, Ramiah T, et al. Pharmacie clinique et pharmacovigilance à l'hôpital: bilan et perspectives après 9 ans d'expérience. Therapie. 2012;67(3):243-250.
Inês RV, Cristina S, Altamiro C-P, Ricardo C-C. Using informatics to promote spontaneous adverse drug reaction reporting. Eur J Integr Med. 2012;4s:194.
Roullet-Renoleau F, Berdot S, Bouvet A, et al. Pharmacist's intervention to improve physician reporting of adverse drug reactions in a French university hospital. Int J Clin Pharmacol. 2012;34(1):226-227.
Ruellan A, Allavena C, Jovelin T, et al. Increase in the rate of spontaneous adverse drug reaction notification and improvement of pharmacologic quality analysis in a department of infectious diseases using an electronic medical record: Nadis®: 05-01. Fundam Clin Pharmacol. 2013;27(Suppl. 1):11-12.
Bona R, Mero P, Piccioni D, et al. Working to improve the ADRs reporting in oncology: an example of cooperation between pharmacists and clinicians. Drug Saf. 2013;36(9):855-855.
Galicia-Quintanar C, Reyes-Garcia J, Fernandez del Vale-Laisequilla C. Prospective longitudinal descriptive study to evaluate the impact of involves physician on training Pharmacovigilance activities in the report of AE. Drug Saf. 2013;36(9):930-930.
Lander AR, Blicher TM, Jimenez-Solem E, Jespersen M, Kampmann JP, Christensen HR. Introducing an adverse drug event manager. Eur J Hosp Pharm. 2013;20(2):78-81.
Goldstein LH, Berlin M, Saliba W, Elias M, Berkovitch M. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital. J Clin Pharmacol. 2013;53(11):1220-1225.
Guglielmi S, Moretti V, Bufarini C, Marinozzi A, De Palma R, Sentinelli R. Ward pharmacist increase reporting of ADRS in one Italian hospital. Int J Clin Pharmacol. 2013;35(5):956-956.
Pochard L, Hauviller L, Cuzin L, Eyvrard F, Sommet A, Montastruc JL, Bagheri H. Use of Nadis® software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées). Therapie 2014;69(2):149-155.
Abadie D, Chebane L, Bert M, Durrieu G, Montastruc JL. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center. Therapie. 2014;69(5):395-400.
Roux M, Abou taam M, Herlem E, Krabansky F, Trenque T. A comparative study in a hospital internal medicine department: spontaneous report vs. stimulated report. Fundam Clin Pharmacol. 2014;28(SUPPL. 1):51.
Ríos OM, Gutiérrez LJ, Talavera JO, et al. A comprehensive intervention for adverse drug reactions identification and reporting in a pediatric emergency department. Int J Clin Pharmacol. 2015;38(1):80-87.
Varallo F, Planeta C, Mastroianni P. Impact of Pharmacovigilance multifaceted educational intervention on knowledge, skills and attitudes of a multidisciplinary healthcare team. Drug Saf. 2015;72(1):1037-1037.
Sørup FKH, Jacobsen CB, Jimenez-Solem E. Increasing the number of spontaneous ADE reports in a Danish region: a retrospective analysis. Pharmaceut Med. 2015;29(4):211-217.
Salcedo De Diego I, Serrano Gallardo P, Ruiz Antorán B, De Andrés Gimeno B, Revuelta Zamorano M, Avendaño Solá C. Impact of a multicomponent intervention on registered nurses to increase reporting of adverse drug reactions and medication errors. Clin Ther. 2015;37(8):e153.
Thomas A, Routledge P, Bracchi R, Carey E, Adams A. Yellow card champions to help increase reporting of adverse drug reactions. Clinical Pharmacist. 2016;8(2).
Canadell L, Olona M, Martín M, et al. Effectiveness of an educational programme to promote a pharmacovigilance system. Eur J Hosp Pharm 2016;23(Suppl 1):A225-226.
Grilli D, Gelsomino F, Massari F, et al. The impact of the clinical pharmacist (CP) in reporting suspected adverse drug reactions (ADRs): the experience of the Medical Oncology Unit at the S. Orsola-Malpighi University Hospital. Ann Oncol. 2016;27(suppl_4):iv115.
Baek HJ, Cho YS, Kim KS, Lee J, Kang HR, Suh DI. Multidisciplinary approach to improve spontaneous ADR reporting in the pediatric outpatient setting: a single-institute experience in Korea. SpringerPlus. 2016;5(1):1435.
Ganesan S, Sandhiya S, Reddy KC, Subrahmanyam D, Adithan C. The impact of the educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among health-care professionals in a tertiary care hospital in South India. J Nat Sc Biol Med. 2017;8(2):203.
Smith A, Hatoun J, Moses J. Increasing trainee reporting of adverse events with monthly trainee-directed review of adverse events. Acad Pediatr. 2017;17(8):902-906.
Lombart A, Dehours E, Durrieu G, Manrique F, Bounes V, Montastruc J. Increased reporting of adverse drug reactions in a hospital emergency department. Fundam Clin Pharmacol. 2017;31(Suppl. 1):62-63.
Chen PC, Lei TH, Tseng CT, Chen LC. Establishment of an information platform increases spontaneous reporting of adverse drug reactions. Int J Clin Pharmacol. 2018;40(1):254.
Humbert X, Chrétien B, Sassier M, Coquerel A, Alexandre J, Fedrizzi S. Evaluation of a new pharmacovigilance tool: simplified online reporting for general practitioners. Sante Publique. 2018;30(2):225-232.
Palleria C, Iannone L, Leporini C, et al. Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP). PloS One. 2018;13(10):e0205134.
He W, Yao D, Hu Y, Dai H. Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China. Ther Clin Risk Manag. 2018;14:2139-2147.
Durrieu G, Jacquot J, Baudrin D, et al. Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits. Therapie. 2017;72(3):351-355.
Terblanche A, Meyer JC, Godman B, Summers RS. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa. Hosp Pract. 2018;46(4):221-228.
Picard S, Polard E, Oger E, Bellissant E. Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years. Therapie. 2015;70(3):293-299.
Khabbal Y, Alami L, Nejjari C. Introduction of pharmacovigilance in a new university hospital in Morocco: how and why. Eastern Mediterranean Health Journal-La Revue de Sante de la Mediterranee Orientale-al-Majallah al-Sihhiyah Li-Sharq al-Mutawassit. 2012;18(6):648-652.
Chen CJ, Cheng CF, Lin HY, Hung SP, Chen WC, Lin MS. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system. J Clin Pharm Ther. 2012;37(6):647-651.
Lowry JA, Sullin AK, Sandritter TL, Leeder JS. Adverse drug reaction surveillance in a pediatric hospital. J Vet Pharmacol Ther. 2013;93(SUPPL. 1):S58.
Al-Braik F, Al Ghufli M, Saad R, Hasan M. Adverse drug reactions monitoring in public hospitals using patient safety network system. Drug Saf. 2016;39(10):1005-1006.
Ejekam CS, Chuka-Ebene VO, Oreagba IA, Olayemi S, Adewumi A. An educational intervention to improve the knowledge and practice of pharmacovigilance among healthcare professionals in private hospitals in Lagos state. Nigeria Pharmacoepidemiology and drug safety. 2015;24:162-163.
Hanafi S, Torkamandi H, Hayatshahi A, Gholami K, Shahmirzadi NA, Javadi MR. An educational intervention to improve nurses' knowledge, attitude, and practice toward reporting of adverse drug reactions. Iran J Nurs Midwifery Res. 2014;19(1):101-106.
Srikanth S, Adepu R. Evaluation of structured educational intervention to community pharmacists towards adverse drug reaction reporting and monitoring in south Indian District. Value Health. 2017;20(9):A688.
Roulet L, Asseray N, Chiffoleau A, Potel G, Ballereau F. Impact of a pharmaceutical presence on adverse drug reaction notification in a French emergency department. Fundam Clin Pharmacol. 2010;24(Suppl. 1):84.
Galfrascoli E, Magni E, Panciroli C, et al. Improving pharmacovigilance in psychiatry. Eur J Hosp Pharm. 2012;19(2):110.
Baniasadi S, Habibi M, Haghgoo R, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014;13(1):291-297.
Valente S, Murray L, Fisher D. Nurses improve medication safety with medication allergy and adverse drug reports. J Nurs Care Qual. 2007;22(4):322-327.
Mahe J, Darnis D, Vrignaud B, Gras-Le-Guen C, Veyrac G, Jolliet P. Pharmacovigilance center and pediatric emergency unit: closer collaboration necessary. Fundam Clin Pharmacol. 2015;29(Suppl. 1):51.
Fornasier G, Taborelli M, Francescon S, et al. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance. Int J Clin Pharmacol. 2018;40(4):795-802.
Abbas A, Green C. The Chester experience-the impact of an intervention to improve adverse drug reactions reporting in a district general hospital. Drug Saf. 2017;40(10):1032-1032.
Fracchiolla NS, Artuso S, Cortelezzi A, et al. FarmaREL: an Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients. Hematol Oncol. 2018;36(1):299-306.
Garza-Ocanas L, Perez-Rdz A, Perez-Garza A, Gonzalez-Nieto C, Escobedo-Pena J, Perez-Rodŕiguez E. ADRS and medication errors surveillance after the implementation of an electronic report system. Drug Saf. 2017;40(10):1013-1014.
Johansson M-L, Brunlöf G, Edward C, Wallerstedt SM. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports. Eur J Clin Pharmacol. 2009;65(5):511-514.
Johansson M-L, Hägg S, Wallerstedt SM. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study. BMC Clin Pharmacol. 2011;11(1):14.
Desai C, Patel S, Patel P, Dikshit R. Effect of educational interventions on reporting of adverse drug reactions by prescribers. Basic Clin Pharmacol Toxicol. 2014;115:68.
Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086-1093.
Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31(4):335-344.
Ribeiro Vaz I, Herdelro M, Figueiras A, Polonia J. Strategies for increasing spontaneous adverse drug reaction reporting rates among Portuguese health professionals. Drug Saf. 2009;32(10):878-879.
Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Polonia J, Falcao A, Figueiras A. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf. 2012;35(8):655-665.
Ratz Y, Shafir I, Berkovitch S, et al. The importance of the pharmacist in reporting adverse drug reactions in the emergency department. J Clin Pharmacol. 2010;50(10):1217-1221.
Prakongsai N, Pongchaideacha M. Using collaborative program between pharmacists and nurses YO improve spontaneous adverse drug reaction reporting system in Thailand. Value Health. 2007;13(7):A537.
Garza-Ocañas L, Perez-Rodríguez E, González-Nieto C, Guzmán-López S. Pharmacovigilance at a university hospital: strategies developed for increasing adverse drug reactions and medication errors reporting. Drug Saf. 2014;37(10):848-849.
Marquez S, Herdeiro M, Ribeiro-Vaz I. An educational intervention to improve nurses reporting of adverse drug reactions. Clin Ther. 2015;37(8):e57.
Srikanth M, Adepu R. Assessment of impact of structured educational intervention on adverse drug reaction reporting behaviour of community pharmacists in South India. Pharmacoepidemiol Drug Saf. 2016;25:417-417.
Vinther S, Klarskov P, Borgeskov H, et al. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions. Dan Med J. 2017;64(1):A5315.
Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in The Netherlands comparing two methods. Drug Saf. 2011;34(9):755-762.
Capucho H, Reis L, Siqueira S, Pereira L. Strategies impact to increase the reporting of pharmacovigilance in a Brazilian university hospital. Drug Saf. 2008;31(10):885-885.
Castel JM, Figueras A, Pedros C, Laporte JR, Capella D. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf. 2003;26(14):1049-1055.
Backstrom M, Mjorndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions-a way of dealing with an old problem? Eur J Clin Pharmacol. 2006;62(5):381-385.
Sánchez I, Amador C, Plaza JC, Correa G, Amador R. Impacto clínico de un sistema de farmacovigilancia activa realizado por un farmacéutico en el reporte y subnotificación de reacciones adversas a medicamentos. Rev Med Chil. 2014;142(8):998-1005.
Schlienger RG, Luscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharmacy World & Science: PWS. 1999;21(3):110-115.
Toutous-Trellu L, Rollason-Gumprecht V, Vogt-Ferrier N. Adverse cutaneous drug reactions: a comparison of spontaneous reporting activities versus proactive pharmacovigilance. Eur Geriatr Med. 2010;1(SUPPL. 1):S88.
Taam MA, Herlem E, Roux M, Trenque T. Drug safety 2.0 in a regional Center of Pharmacovigilance. Fundam Clin Pharmacol. 2015;29(Suppl. 1):66.
Bismuth M, Durrieu G, Mège M, et al. Improving adverse drug reaction reporting by general practitioners in south-west of France. Drug Saf. 2015;38(10):1011-1012.
Jacquot J, Durrieu G, Mege M, et al. Improving adverse drug reaction reporting by general practitioners in south-west of France. Fundam Clin Pharmacol. 2016;30(Suppl. 1):63.
Gony M, Sommet A, Jacquot I, et al. How to improve reporting of adverse drug reactions from hospitals: the results of the pilot study of the French PharmacoMIP over a three-year period. Fundam Clin Pharmacol. 2010;24(Suppl. 1):81-82.
Montastruc F, Bagheri H, Lacroix I, et al. Adverse drug reaction reports received through the Mobile app, VigiBIP([R]): a comparison with classical methods of reporting. Drug Saf. 2018;41(5):511-514.
Humbert X, Alexandre J, Sassier M, Coquerel A, Fedrizzi S. Simplified pharmacovigilance reporting in primary care: one year results. Fundam Clin Pharmacol. 2017;31(Suppl. 1):32-32.
Ribeiro-Vaz I, Santos C, da Costa-Pereira A, Cruz-Correia R. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal. Drug Saf. 2012;35(5):387-394.
Garza-Ocanas L, Escobedo Pena J, Gonzalez-Nieto C, et al. Underreporting adverse drug reactions (ADR) and medication errors (ME): a problem in hospital Pharmacovigilance. Drug Saf. 2015;38(10):985-985.
Hussain SA, Abbas AN, Habeeb S-ZA, Abd-Ali AK, Abdulrahman ZS. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study. Int J Clin Pharmacol. 2019;41(5):1-7.
Varallo FR, Guimarães SOP, Abjaude SAR, Mastroianni PC. Causes for the underreporting of adverse drug events by health professionals: a systematic review. Rev Esc Enferm USP. 2014;48(4):739-747.
Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharmaceutical Journal: SPJ: The Official Publication of the Saudi Pharmaceutical Society. 2018;26(4):453-461.
Akel M, Ramia E, Hajj A, et al. Medication safety spontaneous reporting system: the Lebanese order of pharmacists initiative. Bulletin of Faculty of Pharmacy, Cairo University. 2019;57(1):66-81.
Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists. 2007;64(8):842-849.
van Eekeren R, Rolfes L, Koster AS, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003-1011.